ABPA screening in bronchiectasis: is there a grey zone?

In conclusion, a non-negligible proportion of patients with nonspecific alterations of screening tests at baseline may develop Aspergillus-associated syndromes during follow-up. Future studies are needed to confirm our observations.

Source: European Respiratory Journal - November 19, 2018 Category: Respiratory Medicine Authors: Faverio, P., Bonaiti, G., Stainer, A., De Giacomi, F., Zucchetti, S., Bodini, B. D., Bini, F., Pesci, A. Tags: Respiratory infections Source Type: research